data_2n9o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n9o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.556 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HG3' HD13 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.418 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.427 HD13 ' HG3' ' A' ' 22' ' ' PRO . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 22' ' ' PRO . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.542 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.551 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.65 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.409 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.65 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' SER . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.602 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.624 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.603 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.312 0.577 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 ' HG3' ' A' ' 22' ' ' PRO . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.603 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.438 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.624 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.596 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.533 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.596 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.413 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.507 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.649 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD2' HG13 ' A' ' 37' ' ' ILE . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.546 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 11' ' ' TYR . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.649 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 22' ' ' PRO . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.671 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 32.4 m -105.98 7.54 32.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.96 0.409 . . . . 0.0 111.199 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt -82.9 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.89 6.81 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.96 0.788 . . . . 0.0 109.766 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' OE2' ' HB2' ' A' ' 7' ' ' HIS . 9.2 tp10 69.44 -80.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.344 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 7' ' ' HIS . . . 62.95 -172.74 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.838 0.455 . . . . 0.0 111.992 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.459 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 21.5 t -71.94 -53.28 7.0 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.502 -0.285 . . . . 0.0 111.222 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 5' ' ' SER . 73.9 Cg_endo -76.32 47.54 2.08 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.934 1.756 . . . . 0.0 111.533 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 4' ' ' ALA . 0.9 OUTLIER -67.76 159.39 79.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.388 -175.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 7' ' ' HIS . 27.1 Cg_endo -65.76 165.39 23.48 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.41 2.073 . . . . 0.0 112.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.52 -34.63 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -66.72 105.89 1.68 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 175.268 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.453 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.428 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.6 p -136.33 80.89 1.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 110.907 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt 61.04 41.35 14.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.87 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.72 11.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.312 0.577 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.54 -32.41 11.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 110.52 4.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.006 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 m 62.21 83.71 0.2 Allowed Pre-proline 0 C--O 1.236 0.345 0 O-C-N 123.837 0.711 . . . . 0.0 110.489 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -52.49 140.79 53.57 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.921 2.414 . . . . 0.0 111.777 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -140.86 133.97 14.62 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.598 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -84.07 161.55 13.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.64 2.227 . . . . 0.0 112.088 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.62 -34.37 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 -83.9 107.97 16.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.4 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -154.57 -173.86 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.95 0.375 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 67.96 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.491 0.716 . . . . 0.0 111.925 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.02 -14.59 22.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.375 0.607 . . . . 0.0 109.725 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -82.19 162.25 22.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.706 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.03 133.8 48.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.804 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.8 m -53.45 117.29 11.56 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.866 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 11.9 Cg_exo -70.31 67.7 2.04 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.08 2.52 . . . . 0.0 112.025 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 p-80 -75.18 130.09 81.19 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 28.1 Cg_exo -60.57 120.41 8.13 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.64 -48.24 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.488 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 -84.29 113.3 21.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.556 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -152.99 132.62 13.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 0.0 110.232 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm -86.34 131.25 34.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.037 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 6.93 44.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.548 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.9 -38.59 89.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.966 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.21 126.55 32.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -81.41 133.39 53.36 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 68.4 Cg_endo -74.1 12.36 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.886 2.39 . . . . 0.0 113.14 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.0 t-80 72.15 140.77 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 O-C-N 123.638 0.586 . . . . 0.0 111.005 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 35.2 Cg_exo -60.76 137.6 74.0 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.679 2.253 . . . . 0.0 111.889 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.52 -36.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.977 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 -76.26 104.32 6.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HG3' HD13 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.418 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.427 HD13 ' HG3' ' A' ' 22' ' ' PRO . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 m -78.15 109.78 12.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 110.623 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -134.44 81.78 1.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.88 16.86 23.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 110.289 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -28.79 53.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.48 -42.68 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.5 t -128.56 82.75 67.98 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.61 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.87 137.64 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.825 2.35 . . . . 0.0 111.961 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -142.22 155.12 64.96 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.49 147.73 58.77 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.14 1.893 . . . . 0.0 111.213 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.32 -39.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.109 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.436 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 -80.32 112.74 17.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.55 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HD11 ' HG3' ' A' ' 22' ' ' PRO . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.436 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -137.58 93.54 2.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 110.408 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.48 82.9 7.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.021 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.58 -27.04 15.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.547 0.689 . . . . 0.0 109.535 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -126.9 103.06 7.29 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.931 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.69 0.76 31.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.677 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 m -126.56 93.93 41.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.294 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.52 84.46 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.144 2.563 . . . . 0.0 112.103 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 64.7 t60 -84.9 135.3 40.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 5.9 Cg_endo -83.75 124.97 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.998 2.465 . . . . 0.0 111.924 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.02 -56.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.542 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -73.96 110.83 8.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 175.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.542 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.142 -0.383 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.7 t 64.11 -88.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.293 0.637 . . . . 0.0 111.743 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp -84.16 -8.58 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.0 110.435 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.77 9.4 42.73 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.785 0.802 . . . . 0.0 108.929 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.95 29.5 7.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.81 17.32 24.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.693 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.459 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 t -62.18 -53.86 55.0 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 5' ' ' SER . 18.2 Cg_endo -60.12 133.53 50.56 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.063 1.842 . . . . 0.0 111.579 174.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -90.22 144.8 31.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.86 151.25 62.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.379 2.053 . . . . 0.0 111.64 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.11 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.809 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 -80.36 109.87 15.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.433 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.551 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 45.0 m -114.48 145.39 41.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.687 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.574 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 4.7 mpp? -76.96 66.8 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 -38.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -71.0 -34.3 71.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.496 177.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.45 78.01 1.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.035 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.403 ' C ' ' H ' ' A' ' 7' ' ' HIS . 17.8 t 71.04 129.0 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.796 -178.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 1' ' ' MET . 72.8 Cg_endo -77.78 34.71 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.826 2.351 . . . . 0.0 112.502 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.511 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 69.9 t60 68.57 125.83 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.526 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 14.2 Cg_exo -67.64 134.89 34.15 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.277 2.652 . . . . 0.0 111.87 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -155.07 -40.7 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 -81.58 104.48 12.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.479 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.557 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.3 m 57.79 41.55 24.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.836 0.455 . . . . 0.0 111.734 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt 58.05 31.54 20.8 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.095 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.79 54.18 1.82 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.757 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 71.59 119.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.318 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.11 67.09 6.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.0 m -122.58 151.69 60.46 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.34 -61.46 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.049 2.499 . . . . 0.0 112.479 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 75.8 t60 70.43 133.17 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 123.935 0.772 . . . . 0.0 111.929 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 49.4 Cg_endo -90.74 156.25 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.244 2.629 . . . . 0.0 112.36 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.01 -30.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.964 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -71.73 106.24 4.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.434 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.461 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.8 p -81.42 -25.0 36.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.73 52.13 2.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.346 0.593 . . . . 0.0 111.091 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 41.63 3.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.679 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 57.66 56.12 5.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.634 -174.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.34 -45.5 0.46 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.774 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.9 m -127.04 78.75 73.88 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.27 . . . . 0.0 111.376 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -88.73 29.57 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.886 2.391 . . . . 0.0 111.82 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -140.35 155.74 70.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.967 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.26 125.05 16.36 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.738 2.292 . . . . 0.0 112.319 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -144.65 -47.79 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.364 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -81.91 106.63 13.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.5 p 50.04 78.58 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.639 0.776 . . . . 0.0 111.894 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm -79.88 48.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.25 0.548 . . . . 0.0 110.748 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.22 42.49 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.47 0.652 . . . . 0.0 109.762 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -94.45 13.71 23.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.096 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.36 73.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.571 0.701 . . . . 0.0 109.32 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 m -107.41 106.72 59.11 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.907 169.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.7 -32.92 17.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.719 2.946 . . . . 0.0 113.622 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -145.56 137.2 12.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 110.327 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.06 158.65 24.65 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.794 2.329 . . . . 0.0 111.632 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.64 -51.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.164 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.564 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -72.67 106.7 4.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 178.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.564 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 36.8 t -144.51 135.33 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt 54.38 43.26 30.7 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.594 0.559 . . . . 0.0 110.836 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 -20.6 13.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.702 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.19 -65.97 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.47 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.49 -86.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.837 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.497 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 23.1 t 53.56 59.77 12.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 5' ' ' SER . 86.8 Cg_endo -102.57 15.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.312 2.675 . . . . 0.0 113.485 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.4 149.17 49.24 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.983 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.55 163.79 36.6 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.417 2.078 . . . . 0.0 111.458 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.74 -50.44 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.233 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.65 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -70.39 107.59 3.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 178.048 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.409 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.65 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.8 p -97.28 -22.51 16.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.658 0.229 . . . . 0.0 110.818 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt 70.39 -66.98 0.26 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.878 0.737 . . . . 0.0 111.218 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.41 45.62 0.99 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.561 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -46.47 -55.2 7.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.838 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.49 32.95 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.943 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -152.3 124.65 3.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.713 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.33 124.22 14.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 111.244 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -144.32 143.18 21.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.267 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 132.04 15.76 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.718 2.279 . . . . 0.0 111.367 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 -49.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.504 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.09 106.58 10.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 176.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 17' ' ' SER . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.602 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.602 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.624 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 7.3 t 58.14 29.23 17.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 110.684 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm -92.98 -60.35 1.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 -24.54 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.898 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 60.79 44.18 11.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.73 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.03 -178.44 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.221 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -154.77 91.33 2.99 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.109 0.48 . . . . 0.0 110.468 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.81 -13.51 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.669 2.246 . . . . 0.0 110.617 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.1 p80 -170.8 126.76 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.494 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 36.6 Cg_endo -88.14 -63.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.797 2.332 . . . . 0.0 111.751 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.52 -40.48 0.54 Allowed Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.603 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 -73.24 116.1 13.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.698 -0.751 . . . . 0.0 111.475 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.431 HD12 ' HG3' ' A' ' 22' ' ' PRO . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.603 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.9 p -77.61 127.72 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.686 0.279 . . . . 0.0 111.221 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt 59.08 74.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.144 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.96 20.62 18.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.088 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 58.51 39.64 24.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.143 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.06 -8.85 58.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.516 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.488 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 18.6 m -101.69 -50.13 0.17 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.831 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 5' ' ' SER . 6.7 Cg_exo -73.4 85.68 1.24 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.36 2.04 . . . . 0.0 112.461 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -175.18 157.81 2.07 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.5 119.36 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.895 1.73 . . . . 0.0 111.174 173.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.07 -40.66 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -90.98 104.56 17.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 174.691 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.44 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD21 ' HA ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.438 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.8 m -65.84 -49.61 67.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 111.14 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -111.81 83.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 110.588 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -158.7 59.51 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.782 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 43.4 tt0 73.23 -63.28 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.718 0.636 . . . . 0.0 110.797 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 -175.12 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.135 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m 64.14 93.52 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.761 0.663 . . . . 0.0 110.728 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.03 -164.33 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.623 2.215 . . . . 0.0 112.55 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 36.4 p-80 -55.61 129.15 70.04 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 20.0 Cg_exo -66.39 139.34 53.95 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.58 2.187 . . . . 0.0 111.487 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.85 -50.97 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.968 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 -75.11 107.1 6.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.417 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' H ' ' HB ' ' A' ' 28' ' ' ILE . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.417 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.624 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.1 m -119.25 90.02 3.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.02 0.438 . . . . 0.0 110.911 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.87 126.9 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.85 33.23 1.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -98.22 -83.83 0.4 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.177 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.16 -51.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 t -170.73 74.9 0.57 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.551 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.54 136.13 69.21 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.737 2.291 . . . . 0.0 112.083 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 12.5 p80 -132.88 126.21 19.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.772 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 13.8 Cg_exo -68.94 135.53 32.69 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.833 2.355 . . . . 0.0 111.843 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.7 -42.77 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.379 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.596 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.72 112.6 16.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 177.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.421 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.433 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.533 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.596 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.9 t -127.86 100.53 5.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.895 0.378 . . . . 0.0 110.127 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -88.93 4.87 46.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.82 -62.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.604 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -170.52 -100.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.146 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.52 62.23 2.54 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 174.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -172.59 -59.0 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.68 -35.75 78.58 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.985 1.79 . . . . 0.0 113.052 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -172.27 151.62 2.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.409 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.44 135.66 11.98 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.402 2.068 . . . . 0.0 110.97 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.4 -33.77 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.969 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.539 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -85.3 112.91 21.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 175.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.446 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.413 ' HB ' ' H ' ' A' ' 29' ' ' CYS . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.507 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.507 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 p -121.83 -5.15 9.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -139.44 167.4 22.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.754 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.89 25.11 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.933 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -106.9 162.33 13.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.627 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.66 -81.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.964 0.79 . . . . 0.0 111.639 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.591 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 15.2 m -133.9 -58.0 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.563 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 5' ' ' SER . 9.3 Cg_endo -52.52 132.57 45.81 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.35 2.034 . . . . 0.0 112.269 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -148.64 132.99 8.81 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.985 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -81.99 160.89 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.681 2.254 . . . . 0.0 111.879 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.22 -43.14 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.98 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.649 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 -75.15 106.14 6.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD2' HG13 ' A' ' 37' ' ' ILE . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.41 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.41 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HG13 ' CD2' ' A' ' 11' ' ' TYR . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.649 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.4 m -66.89 139.15 57.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.679 0.276 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 67.36 8.85 6.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.36 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.54 -17.93 7.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.57 68.91 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 110.811 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.65 18.71 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.376 0.607 . . . . 0.0 109.882 175.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -131.26 96.29 22.26 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.497 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.29 -29.02 39.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.288 1.992 . . . . 0.0 109.732 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -124.42 132.85 24.35 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.2 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.37 -71.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.27 1.98 . . . . 0.0 112.75 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.08 -32.72 1.88 Allowed Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.269 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.671 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 -68.68 106.26 2.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.431 ' SG ' ' HB3' ' A' ' 15' ' ' CYS . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.431 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.407 HD12 ' HG3' ' A' ' 22' ' ' PRO . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.671 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.47 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 20' ' ' ILE . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' ILE . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HG22 ' A' ' 37' ' ' ILE . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' A' ' 37' ' ' ILE . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 20' ' ' ILE . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' O ' HG13 ' A' ' 18' ' ' VAL . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 16' ' ' CYS . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 28' ' ' ILE . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG21 HD11 ' A' ' 20' ' ' ILE . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 37' ' ' ILE . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 37' ' ' ILE . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.434 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HA ' HG22 ' A' ' 37' ' ' ILE . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.408 ' O ' HG13 ' A' ' 18' ' ' VAL . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' CYS . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 37' ' ' ILE . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 20' ' ' ILE . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' HG12 ' A' ' 28' ' ' ILE . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 26' ' ' ASP . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.66 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.312 0.577 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.415 ' CB ' HG22 ' A' ' 18' ' ' VAL . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 16' ' ' CYS . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.618 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG21 HH11 ' A' ' 31' ' ' ARG . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.435 HH11 HG21 ' A' ' 18' ' ' VAL . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG21 HD11 ' A' ' 20' ' ' ILE . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.606 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 37' ' ' ILE . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 28' ' ' ILE . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 26' ' ' ASP . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 20' ' ' ILE . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB2' HG12 ' A' ' 28' ' ' ILE . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 26' ' ' ASP . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 20' ' ' ILE . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.659 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.659 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.683 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 18' ' ' VAL . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 16' ' ' CYS . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 37' ' ' ILE . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.683 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 32.4 m -105.98 7.54 32.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.96 0.409 . . . . 0.0 111.199 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt -82.9 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.89 6.81 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.96 0.788 . . . . 0.0 109.766 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' OE2' ' HB2' ' A' ' 7' ' ' HIS . 9.2 tp10 69.44 -80.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.344 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' HIS . . . 62.95 -172.74 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.838 0.455 . . . . 0.0 111.992 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 21.5 t -71.94 -53.28 7.0 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.502 -0.285 . . . . 0.0 111.222 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' SER . 73.9 Cg_endo -76.32 47.54 2.08 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.934 1.756 . . . . 0.0 111.533 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -67.76 159.39 79.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.388 -175.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 7' ' ' HIS . 27.1 Cg_endo -65.76 165.39 23.48 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.41 2.073 . . . . 0.0 112.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.52 -34.63 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -66.72 105.89 1.68 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 175.268 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.6 p -136.33 80.89 1.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 110.907 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt 61.04 41.35 14.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.87 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.72 11.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.312 0.577 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.54 -32.41 11.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 110.52 4.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.006 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 m 62.21 83.71 0.2 Allowed Pre-proline 0 C--O 1.236 0.345 0 O-C-N 123.837 0.711 . . . . 0.0 110.489 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -52.49 140.79 53.57 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.921 2.414 . . . . 0.0 111.777 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -140.86 133.97 14.62 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.598 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -84.07 161.55 13.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.64 2.227 . . . . 0.0 112.088 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.62 -34.37 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 -83.9 107.97 16.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.47 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 20' ' ' ILE . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -154.57 -173.86 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.95 0.375 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 67.96 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.491 0.716 . . . . 0.0 111.925 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.02 -14.59 22.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.375 0.607 . . . . 0.0 109.725 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -82.19 162.25 22.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.706 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.03 133.8 48.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.804 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.8 m -53.45 117.29 11.56 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.866 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 11.9 Cg_exo -70.31 67.7 2.04 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.08 2.52 . . . . 0.0 112.025 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 p-80 -75.18 130.09 81.19 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 28.1 Cg_exo -60.57 120.41 8.13 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.64 -48.24 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.488 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 -84.29 113.3 21.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' ILE . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -152.99 132.62 13.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 0.0 110.232 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm -86.34 131.25 34.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.037 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 6.93 44.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.548 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.9 -38.59 89.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.966 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.21 126.55 32.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -81.41 133.39 53.36 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 68.4 Cg_endo -74.1 12.36 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.886 2.39 . . . . 0.0 113.14 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.0 t-80 72.15 140.77 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 O-C-N 123.638 0.586 . . . . 0.0 111.005 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 35.2 Cg_exo -60.76 137.6 74.0 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.679 2.253 . . . . 0.0 111.889 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.52 -36.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.977 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 -76.26 104.32 6.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HG22 ' A' ' 37' ' ' ILE . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 m -78.15 109.78 12.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 110.623 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -134.44 81.78 1.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.88 16.86 23.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 110.289 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -28.79 53.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.48 -42.68 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.5 t -128.56 82.75 67.98 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.61 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.87 137.64 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.825 2.35 . . . . 0.0 111.961 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -142.22 155.12 64.96 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.49 147.73 58.77 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.14 1.893 . . . . 0.0 111.213 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.32 -39.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.109 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 -80.32 112.74 17.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' A' ' 37' ' ' ILE . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 20' ' ' ILE . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -137.58 93.54 2.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 110.408 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.48 82.9 7.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.021 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.58 -27.04 15.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.547 0.689 . . . . 0.0 109.535 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -126.9 103.06 7.29 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.931 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.69 0.76 31.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.677 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 m -126.56 93.93 41.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.294 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.52 84.46 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.144 2.563 . . . . 0.0 112.103 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 64.7 t60 -84.9 135.3 40.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 5.9 Cg_endo -83.75 124.97 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.998 2.465 . . . . 0.0 111.924 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.02 -56.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -73.96 110.83 8.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 175.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' O ' HG13 ' A' ' 18' ' ' VAL . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 16' ' ' CYS . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 28' ' ' ILE . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG21 HD11 ' A' ' 20' ' ' ILE . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.142 -0.383 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.7 t 64.11 -88.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.293 0.637 . . . . 0.0 111.743 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp -84.16 -8.58 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.0 110.435 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.77 9.4 42.73 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.785 0.802 . . . . 0.0 108.929 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.95 29.5 7.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.81 17.32 24.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.693 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.461 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 t -62.18 -53.86 55.0 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 174.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 5' ' ' SER . 18.2 Cg_endo -60.12 133.53 50.56 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.063 1.842 . . . . 0.0 111.579 174.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -90.22 144.8 31.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.86 151.25 62.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.379 2.053 . . . . 0.0 111.64 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.11 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.809 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 -80.36 109.87 15.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 45.0 m -114.48 145.39 41.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.687 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 4.7 mpp? -76.96 66.8 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 -38.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 0' ' ' SER . 14.6 pt-20 -71.0 -34.3 71.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.496 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.45 78.01 1.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.035 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 t 71.04 129.0 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.796 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' MET . 72.8 Cg_endo -77.78 34.71 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.826 2.351 . . . . 0.0 112.502 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.53 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 69.9 t60 68.57 125.83 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.526 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 14.2 Cg_exo -67.64 134.89 34.15 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.277 2.652 . . . . 0.0 111.87 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -155.07 -40.7 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 -81.58 104.48 12.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 37' ' ' ILE . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.3 m 57.79 41.55 24.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.836 0.455 . . . . 0.0 111.734 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt 58.05 31.54 20.8 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.095 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.79 54.18 1.82 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.757 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 71.59 119.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.318 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.11 67.09 6.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.0 m -122.58 151.69 60.46 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.34 -61.46 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.049 2.499 . . . . 0.0 112.479 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 75.8 t60 70.43 133.17 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 123.935 0.772 . . . . 0.0 111.929 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 49.4 Cg_endo -90.74 156.25 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.244 2.629 . . . . 0.0 112.36 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.01 -30.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.964 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -71.73 106.24 4.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 37' ' ' ILE . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.434 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.8 p -81.42 -25.0 36.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.73 52.13 2.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.346 0.593 . . . . 0.0 111.091 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 41.63 3.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.679 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 57.66 56.12 5.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.634 -174.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.34 -45.5 0.46 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.774 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.9 m -127.04 78.75 73.88 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.27 . . . . 0.0 111.376 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -88.73 29.57 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.886 2.391 . . . . 0.0 111.82 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -140.35 155.74 70.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.967 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.26 125.05 16.36 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.738 2.292 . . . . 0.0 112.319 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -144.65 -47.79 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.364 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -81.91 106.63 13.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HA ' HG22 ' A' ' 37' ' ' ILE . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.408 ' O ' HG13 ' A' ' 18' ' ' VAL . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' CYS . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 37' ' ' ILE . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 20' ' ' ILE . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.5 p 50.04 78.58 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.639 0.776 . . . . 0.0 111.894 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm -79.88 48.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.25 0.548 . . . . 0.0 110.748 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.22 42.49 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.47 0.652 . . . . 0.0 109.762 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -94.45 13.71 23.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.096 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.36 73.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.571 0.701 . . . . 0.0 109.32 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 m -107.41 106.72 59.11 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.907 169.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.7 -32.92 17.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.719 2.946 . . . . 0.0 113.622 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -145.56 137.2 12.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 110.327 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.06 158.65 24.65 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.794 2.329 . . . . 0.0 111.632 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.64 -51.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.164 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -72.67 106.7 4.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 178.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 36.8 t -144.51 135.33 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt 54.38 43.26 30.7 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.594 0.559 . . . . 0.0 110.836 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 -20.6 13.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.702 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.19 -65.97 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.47 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.49 -86.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.837 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.493 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 23.1 t 53.56 59.77 12.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 5' ' ' SER . 86.8 Cg_endo -102.57 15.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.312 2.675 . . . . 0.0 113.485 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.4 149.17 49.24 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.983 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.55 163.79 36.6 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.417 2.078 . . . . 0.0 111.458 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.74 -50.44 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.233 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -70.39 107.59 3.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 178.048 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' HG12 ' A' ' 28' ' ' ILE . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 26' ' ' ASP . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.66 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.8 p -97.28 -22.51 16.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.658 0.229 . . . . 0.0 110.818 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt 70.39 -66.98 0.26 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.878 0.737 . . . . 0.0 111.218 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.41 45.62 0.99 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.561 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -46.47 -55.2 7.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.838 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.49 32.95 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.943 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -152.3 124.65 3.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.713 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.33 124.22 14.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 111.244 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -144.32 143.18 21.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.267 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 132.04 15.76 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.718 2.279 . . . . 0.0 111.367 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 -49.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.504 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.09 106.58 10.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 176.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 7.3 t 58.14 29.23 17.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 110.684 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm -92.98 -60.35 1.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 -24.54 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.898 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 60.79 44.18 11.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.73 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.03 -178.44 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.221 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -154.77 91.33 2.99 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.109 0.48 . . . . 0.0 110.468 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.81 -13.51 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.669 2.246 . . . . 0.0 110.617 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 39.8 p-80 -170.8 126.76 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.494 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 36.6 Cg_endo -88.14 -63.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.797 2.332 . . . . 0.0 111.751 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.52 -40.48 0.54 Allowed Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 -73.24 116.1 13.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.698 -0.751 . . . . 0.0 111.475 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.415 ' CB ' HG22 ' A' ' 18' ' ' VAL . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 16' ' ' CYS . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.9 p -77.61 127.72 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.686 0.279 . . . . 0.0 111.221 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt 59.08 74.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.144 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.96 20.62 18.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.088 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 58.51 39.64 24.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.143 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.06 -8.85 58.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.516 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 18.6 m -101.69 -50.13 0.17 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.831 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 5' ' ' SER . 6.7 Cg_exo -73.4 85.68 1.24 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.36 2.04 . . . . 0.0 112.461 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -175.18 157.81 2.07 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.5 119.36 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.895 1.73 . . . . 0.0 111.174 173.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.07 -40.66 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -90.98 104.56 17.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 174.691 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG21 HH11 ' A' ' 31' ' ' ARG . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.435 HH11 HG21 ' A' ' 18' ' ' VAL . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG21 HD11 ' A' ' 20' ' ' ILE . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.8 m -65.84 -49.61 67.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 111.14 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -111.81 83.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 110.588 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -158.7 59.51 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.782 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 43.4 tt0 73.23 -63.28 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.718 0.636 . . . . 0.0 110.797 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 -175.12 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.135 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m 64.14 93.52 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.761 0.663 . . . . 0.0 110.728 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.03 -164.33 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.623 2.215 . . . . 0.0 112.55 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 36.4 p-80 -55.61 129.15 70.04 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 20.0 Cg_exo -66.39 139.34 53.95 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.58 2.187 . . . . 0.0 111.487 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.85 -50.97 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.968 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 -75.11 107.1 6.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.1 m -119.25 90.02 3.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.02 0.438 . . . . 0.0 110.911 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.87 126.9 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.85 33.23 1.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -98.22 -83.83 0.4 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.177 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.16 -51.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 t -170.73 74.9 0.57 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.551 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.54 136.13 69.21 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.737 2.291 . . . . 0.0 112.083 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 12.5 p80 -132.88 126.21 19.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.772 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 13.8 Cg_exo -68.94 135.53 32.69 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.833 2.355 . . . . 0.0 111.843 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.7 -42.77 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.379 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.606 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.72 112.6 16.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 177.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 37' ' ' ILE . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 28' ' ' ILE . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 26' ' ' ASP . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 20' ' ' ILE . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.9 t -127.86 100.53 5.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.895 0.378 . . . . 0.0 110.127 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -88.93 4.87 46.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.82 -62.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.604 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -170.52 -100.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.146 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB2' HH12 ' A' ' 10' ' ' ARG . . . 47.52 62.23 2.54 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -172.59 -59.0 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.68 -35.75 78.58 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.985 1.79 . . . . 0.0 113.052 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -172.27 151.62 2.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.409 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.44 135.66 11.98 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.402 2.068 . . . . 0.0 110.97 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.4 -33.77 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.969 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -85.3 112.91 21.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 175.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB2' HG12 ' A' ' 28' ' ' ILE . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 26' ' ' ASP . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 20' ' ' ILE . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 p -121.83 -5.15 9.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -139.44 167.4 22.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.754 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.89 25.11 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.933 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -106.9 162.33 13.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.627 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.66 -81.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.964 0.79 . . . . 0.0 111.639 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 15.2 m -133.9 -58.0 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.563 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 5' ' ' SER . 9.3 Cg_endo -52.52 132.57 45.81 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.35 2.034 . . . . 0.0 112.269 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -148.64 132.99 8.81 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.985 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -81.99 160.89 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.681 2.254 . . . . 0.0 111.879 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.22 -43.14 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.98 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.659 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 -75.15 106.14 6.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.659 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.4 m -66.89 139.15 57.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.679 0.276 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 67.36 8.85 6.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.36 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.54 -17.93 7.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.57 68.91 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 110.811 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.65 18.71 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.376 0.607 . . . . 0.0 109.882 175.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -131.26 96.29 22.26 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.497 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.29 -29.02 39.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.288 1.992 . . . . 0.0 109.732 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -124.42 132.85 24.35 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.2 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.37 -71.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.27 1.98 . . . . 0.0 112.75 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.08 -32.72 1.88 Allowed Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.269 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.683 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 -68.68 106.26 2.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 18' ' ' VAL . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 16' ' ' CYS . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 37' ' ' ILE . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.683 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 . . . . . 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.47 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 20' ' ' ILE . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 . . . . . 0 N--CA 1.447 -0.595 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' ILE . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.486 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HG22 ' A' ' 37' ' ' ILE . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' A' ' 37' ' ' ILE . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 20' ' ' ILE . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.313 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.452 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.404 ' O ' HG13 ' A' ' 18' ' ' VAL . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 16' ' ' CYS . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 28' ' ' ILE . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG21 HD11 ' A' ' 20' ' ' ILE . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.452 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 . . . . . 0 N--CA 1.446 -0.627 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 37' ' ' ILE . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.466 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 37' ' ' ILE . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.434 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 . . . . . 0 N--CA 1.445 -0.705 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HA ' HG22 ' A' ' 37' ' ' ILE . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.408 ' O ' HG13 ' A' ' 18' ' ' VAL . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' CYS . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 37' ' ' ILE . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 20' ' ' ILE . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.246 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.286 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' HG12 ' A' ' 28' ' ' ILE . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 26' ' ' ASP . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.66 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.447 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.312 0.577 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.415 ' CB ' HG22 ' A' ' 18' ' ' VAL . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 16' ' ' CYS . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.618 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.435 HG21 HH11 ' A' ' 31' ' ' ARG . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.435 HH11 HG21 ' A' ' 18' ' ' VAL . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.533 HG21 HD11 ' A' ' 20' ' ' ILE . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.606 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 37' ' ' ILE . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 28' ' ' ILE . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 26' ' ' ASP . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.545 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 20' ' ' ILE . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.606 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.549 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB2' HG12 ' A' ' 28' ' ' ILE . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 26' ' ' ASP . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 20' ' ' ILE . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.659 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.576 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.659 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.683 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 18' ' ' VAL . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 16' ' ' CYS . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 37' ' ' ILE . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.683 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.717 -0.553 . . . . 0.0 111.717 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 32.4 m -105.98 7.54 32.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.96 0.409 . . . . 0.0 111.199 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt -82.9 140.3 32.93 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 67.32 30.89 6.81 Favored 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.96 0.788 . . . . 0.0 109.766 -176.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' OE2' ' HB2' ' A' ' 7' ' ' HIS . 9.2 tp10 69.44 -80.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.344 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' A' ' 7' ' ' HIS . . . 62.95 -172.74 0.16 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.838 0.455 . . . . 0.0 111.992 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.487 ' HB3' ' HD3' ' A' ' 6' ' ' PRO . 21.5 t -71.94 -53.28 7.0 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-O 119.502 -0.285 . . . . 0.0 111.222 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.487 ' HD3' ' HB3' ' A' ' 5' ' ' SER . 73.9 Cg_endo -76.32 47.54 2.08 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.934 1.756 . . . . 0.0 111.533 174.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.479 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 0.9 OUTLIER -67.76 159.39 79.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.388 -175.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 7' ' ' HIS . 27.1 Cg_endo -65.76 165.39 23.48 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.41 2.073 . . . . 0.0 112.327 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.52 -34.63 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 0.8 OUTLIER -66.72 105.89 1.68 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.445 0.64 . . . . 0.0 110.385 175.268 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -114.31 163.24 15.55 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.28 177.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -129.39 110.55 12.0 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.953 177.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 12.7 t -76.52 132.31 39.48 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.552 -177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.8 m170 -75.36 -29.49 59.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.117 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.9 t -74.69 -46.29 38.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.459 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 78.9 m -87.3 -18.26 30.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.6 p 50.89 42.13 27.66 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.604 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.3 m -136.72 166.21 26.62 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.906 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -83.8 131.94 34.86 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.484 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -135.56 168.39 23.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.433 0.635 . . . . 0.0 111.499 -173.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.97 109.62 40.91 Favored Pre-proline 0 C--N 1.317 -0.837 0 CA-C-N 114.97 -1.014 . . . . 0.0 108.432 168.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.8 Cg_exo -64.7 150.34 88.32 Favored 'Trans proline' 0 CA--C 1.517 -0.357 0 C-N-CA 122.947 2.431 . . . . 0.0 113.109 -172.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -72.65 100.33 2.78 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 168.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.33 -42.24 95.2 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -169.335 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -56.38 -23.54 47.3 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.099 1.866 . . . . 0.0 113.386 175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.456 ' HB2' HG12 ' A' ' 28' ' ' ILE . 43.8 m-20 -115.24 -22.14 9.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.893 0.378 . . . . 0.0 111.75 -176.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 57.6 40.39 26.81 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.759 -173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 26' ' ' ASP . 24.0 pt -115.38 -171.83 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.562 0.696 . . . . 0.0 111.439 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.49 141.34 30.38 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.25 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -79.95 -9.36 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.241 1.961 . . . . 0.0 111.016 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -102.31 -50.88 3.49 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.683 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.1 p -115.29 -9.4 12.21 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 119.743 -0.783 . . . . 0.0 112.49 -173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 59.34 37.95 23.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.2 t -91.75 -57.48 2.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.934 -174.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -25.07 7.91 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.834 -177.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.481 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 47.1 m-85 -67.2 85.22 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 122.563 0.345 . . . . 0.0 111.13 175.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 7.0 pt -138.16 153.24 26.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 33.9 mt-10 -113.92 127.53 56.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.812 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -80.5 108.69 14.34 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.383 -0.817 . . . . 0.0 111.702 -171.55 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 13.6 p -136.33 80.89 1.85 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.9 0.381 . . . . 0.0 110.907 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt 61.04 41.35 14.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.87 175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.22 -31.72 11.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.312 0.577 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.54 -32.41 11.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.404 175.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -69.25 110.52 4.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.006 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.8 m 62.21 83.71 0.2 Allowed Pre-proline 0 C--O 1.236 0.345 0 O-C-N 123.837 0.711 . . . . 0.0 110.489 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -52.49 140.79 53.57 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.921 2.414 . . . . 0.0 111.777 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -140.86 133.97 14.62 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.598 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -84.07 161.55 13.59 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.64 2.227 . . . . 0.0 112.088 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.62 -34.37 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 10' ' ' ARG . 3.6 ptp180 -83.9 107.97 16.61 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.479 0.657 . . . . 0.0 109.978 174.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.421 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 15.4 m-85 -119.84 161.78 20.23 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.471 178.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -124.87 110.69 14.58 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.93 175.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.485 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.6 t -75.31 133.29 41.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.566 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.3 m170 -85.71 -16.29 39.51 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.094 0.473 . . . . 0.0 110.854 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 75.5 m -85.99 -28.5 24.17 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.815 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.8 m -107.64 -14.5 14.8 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.222 0.534 . . . . 0.0 111.07 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.5 p 51.96 42.87 30.56 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.761 -1.109 . . . . 0.0 111.75 -174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -139.49 165.08 23.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.296 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.44 128.41 35.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.624 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.529 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.08 167.15 27.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.532 0.682 . . . . 0.0 111.557 -171.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -116.06 105.31 51.25 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.404 169.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 31.0 Cg_exo -63.27 153.85 71.67 Favored 'Trans proline' 0 CA--C 1.516 -0.396 0 C-N-CA 123.404 2.736 . . . . 0.0 113.926 -170.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.75 100.1 4.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 170.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.01 -46.04 98.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -164.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -54.68 -27.08 49.81 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.213 1.942 . . . . 0.0 113.051 179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -112.0 -16.9 12.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.884 0.373 . . . . 0.0 111.577 -178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 56.47 36.36 27.42 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.356 -175.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.5 pt -108.93 -172.48 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.676 0.75 . . . . 0.0 111.55 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.9 t -88.07 142.28 31.84 Favored Pre-proline 0 C--N 1.315 -0.907 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.245 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.75 -6.2 11.53 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.115 1.877 . . . . 0.0 110.364 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.6 mtt180 -103.35 -51.36 3.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.978 -176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 28.7 p -116.26 -9.77 11.52 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 120.192 -0.603 . . . . 0.0 112.548 -174.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 57.15 38.47 28.98 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.574 177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.6 -57.76 2.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.654 -174.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.65 -24.57 7.15 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.928 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.47 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.4 m-85 -67.28 84.13 0.15 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.758 0.313 . . . . 0.0 111.073 175.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 20' ' ' ILE . 10.0 pt -137.89 149.99 25.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.793 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -113.07 124.13 51.89 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.663 -178.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -75.48 104.05 5.87 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.549 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.369 -0.824 . . . . 0.0 111.611 -172.515 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.891 0 N-CA-C 111.798 -0.521 . . . . 0.0 111.798 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 66.3 m -154.57 -173.86 4.74 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.95 0.375 . . . . 0.0 110.396 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt 67.96 -82.54 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.491 0.716 . . . . 0.0 111.925 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.02 -14.59 22.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.375 0.607 . . . . 0.0 109.725 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -82.19 162.25 22.47 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.706 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.03 133.8 48.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.804 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.447 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 32.8 m -53.45 117.29 11.56 Favored Pre-proline 0 C--O 1.235 0.336 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.866 -175.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 5' ' ' SER . 11.9 Cg_exo -70.31 67.7 2.04 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 123.08 2.52 . . . . 0.0 112.025 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 40.1 p-80 -75.18 130.09 81.19 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.477 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 28.1 Cg_exo -60.57 120.41 8.13 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.417 2.078 . . . . 0.0 112.119 -178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.64 -48.24 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.488 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 4.6 ptp180 -84.29 113.3 21.03 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.265 0.555 . . . . 0.0 110.571 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.401 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.6 m-85 -124.42 165.8 17.1 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.49 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -129.13 111.17 12.66 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.486 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 35.5 t -74.72 133.24 42.06 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.404 -178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m170 -87.47 -13.23 43.73 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.25 0.548 . . . . 0.0 110.838 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.569 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 63.3 m -86.19 -33.01 20.91 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.323 177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 72.2 m -103.3 -14.43 16.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.262 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.9 p 50.67 39.65 22.16 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.222 1.009 . . . . 0.0 111.806 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.01 163.6 34.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.435 178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -81.83 128.68 34.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.311 -0.858 . . . . 0.0 109.411 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.524 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -133.87 168.33 24.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.371 0.605 . . . . 0.0 111.655 -173.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.71 109.85 41.09 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-N 114.736 -1.12 . . . . 0.0 108.354 168.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 27.6 Cg_exo -64.51 150.34 88.4 Favored 'Trans proline' 0 CA--C 1.514 -0.523 0 C-N-CA 123.077 2.518 . . . . 0.0 113.424 -172.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -73.82 99.17 3.12 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 169.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -53.84 -46.88 98.31 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -165.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -57.15 -24.48 58.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.211 1.941 . . . . 0.0 113.31 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -110.24 -19.15 13.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.961 0.41 . . . . 0.0 111.501 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 55.7 40.72 30.87 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.607 -175.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 20.7 pt -116.0 -172.26 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.607 0.718 . . . . 0.0 111.363 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.2 t -88.38 141.14 30.42 Favored Pre-proline 0 C--N 1.315 -0.899 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.286 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.91 -16.16 16.28 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 121.984 1.789 . . . . 0.0 110.681 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.4 mtp180 -95.02 -51.94 4.44 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.543 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.3 p -115.22 -9.53 12.24 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 119.821 -0.751 . . . . 0.0 112.721 -172.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 58.94 32.03 21.87 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.103 0.478 . . . . 0.0 111.596 175.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.4 t -89.04 -56.55 3.24 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.731 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.81 -22.91 7.56 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.223 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 31.4 m-85 -70.45 86.13 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.936 0.398 . . . . 0.0 110.728 175.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.524 HG21 HD11 ' A' ' 20' ' ' ILE . 8.6 pt -138.05 146.02 27.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.53 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -112.39 118.14 34.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.048 -175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -69.85 112.45 6.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.235 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.486 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.5 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.633 -0.698 . . . . 0.0 111.41 -173.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.942 -0.463 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 23.8 t -152.99 132.62 13.06 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.755 0.312 . . . . 0.0 110.232 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtm -86.34 131.25 34.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.037 176.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.99 6.93 44.47 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.066 0.46 . . . . 0.0 110.548 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -65.9 -38.59 89.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.966 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.21 126.55 32.76 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.511 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 6.2 p -81.41 133.39 53.36 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.194 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 7' ' ' HIS . 68.4 Cg_endo -74.1 12.36 1.02 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.886 2.39 . . . . 0.0 113.14 -178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 45.0 t-80 72.15 140.77 0.08 OUTLIER Pre-proline 0 CA--C 1.533 0.325 0 O-C-N 123.638 0.586 . . . . 0.0 111.005 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 35.2 Cg_exo -60.76 137.6 74.0 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.679 2.253 . . . . 0.0 111.889 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.52 -36.85 0.18 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.711 -0.757 . . . . 0.0 111.977 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.1 ptp180 -76.26 104.32 6.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.506 0.669 . . . . 0.0 110.323 176.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.42 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 11.6 m-85 -117.49 165.34 13.65 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.247 177.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.7 t80 -128.6 111.46 13.23 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.847 176.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.452 ' HA ' HG22 ' A' ' 37' ' ' ILE . 20.0 t -77.68 132.79 38.35 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.464 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -82.03 -18.67 42.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.857 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 64.5 m -85.61 -25.45 26.66 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.072 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -110.06 -15.7 13.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.271 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 81.1 p 50.74 42.57 27.64 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.382 1.073 . . . . 0.0 111.723 -172.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.3 m -138.32 164.4 27.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.293 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -85.47 128.33 34.7 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.442 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.56 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -132.51 167.84 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.374 0.607 . . . . 0.0 111.655 -172.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -115.59 110.4 44.73 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.391 167.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.468 ' HG3' HD12 ' A' ' 37' ' ' ILE . 34.2 Cg_exo -60.67 146.85 96.49 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.994 2.463 . . . . 0.0 113.64 -170.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -73.61 102.82 4.01 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 171.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.75 -46.05 98.54 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -164.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -49.94 -43.39 41.69 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.084 1.856 . . . . 0.0 113.155 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -104.06 -11.81 17.15 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 57.15 39.28 29.06 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.335 -176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 11.5 pt -109.37 -168.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.505 0.669 . . . . 0.0 111.354 -178.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.25 141.68 32.92 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.146 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -80.9 -10.71 12.71 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.933 1.755 . . . . 0.0 110.399 178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.9 mtp180 -99.07 -51.37 3.86 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.58 -177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.4 p -116.9 -8.04 11.34 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.231 -174.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 57.49 34.9 25.24 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.999 0.428 . . . . 0.0 111.859 175.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.4 t -90.14 -57.35 2.88 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.401 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.27 -22.32 7.95 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.403 -0.904 . . . . 0.0 111.986 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 36.0 m-85 -68.48 86.05 0.29 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.766 0.317 . . . . 0.0 111.243 176.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.56 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -137.72 149.31 25.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.032 -178.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -113.72 131.23 56.26 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.658 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -79.46 119.8 22.97 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 89.1 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.692 -0.67 . . . . 0.0 111.831 -172.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.117 -0.393 . . . . 0.0 112.117 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 25.4 m -78.15 109.78 12.54 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.881 0.372 . . . . 0.0 110.623 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt -134.44 81.78 1.93 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.88 16.86 23.76 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.158 0.504 . . . . 0.0 110.289 177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -28.79 53.86 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.958 -175.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -148.48 -42.68 0.15 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.842 0.353 . . . . 0.0 111.014 178.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.5 t -128.56 82.75 67.98 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.61 -178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -69.87 137.64 35.61 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.825 2.35 . . . . 0.0 111.961 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -142.22 155.12 64.96 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.132 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -70.49 147.73 58.77 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 122.14 1.893 . . . . 0.0 111.213 175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.32 -39.65 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.109 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 2.7 ptp180 -80.32 112.74 17.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.293 0.568 . . . . 0.0 110.27 176.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -125.86 164.95 19.61 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.202 0.525 . . . . 0.0 111.165 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -129.36 111.7 13.1 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.775 176.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.488 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.6 t -76.33 134.38 39.72 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.448 -178.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -79.31 -33.96 42.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.209 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 32.0 m -67.55 -38.38 84.07 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.789 -179.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 74.4 m -99.07 -16.06 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.036 0.446 . . . . 0.0 111.201 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.0 p 50.87 40.59 25.26 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.304 1.042 . . . . 0.0 111.969 -173.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.47 164.83 28.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.366 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -81.75 131.41 35.26 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.682 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.534 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.62 169.04 20.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.395 0.617 . . . . 0.0 111.644 -173.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -119.23 112.04 36.34 Favored Pre-proline 0 C--N 1.318 -0.8 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.157 168.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' A' ' 37' ' ' ILE . 21.9 Cg_exo -65.81 153.41 78.24 Favored 'Trans proline' 0 CA--C 1.517 -0.348 0 C-N-CA 122.748 2.299 . . . . 0.0 113.489 -172.009 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -78.01 100.35 6.44 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.12 -45.73 88.69 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 -166.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -54.21 -31.44 66.12 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.96 1.773 . . . . 0.0 113.231 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -112.9 -13.93 13.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.902 0.382 . . . . 0.0 111.85 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 54.31 35.72 23.53 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.679 -174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 22.2 pt -104.8 -176.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.6 0.714 . . . . 0.0 111.415 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -88.07 142.53 32.04 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.633 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -79.43 -12.82 13.85 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.033 1.822 . . . . 0.0 110.789 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.505 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -98.64 -43.58 6.77 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.826 -177.788 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.1 p -124.71 -8.39 7.34 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 119.771 -0.772 . . . . 0.0 112.919 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 58.38 34.34 23.92 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.916 0.389 . . . . 0.0 111.645 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 11.9 t -92.91 -57.41 2.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.704 -174.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 116.7 -14.43 14.69 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.626 178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 13.2 m-85 -73.2 83.93 1.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.96 0.409 . . . . 0.0 110.52 175.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 20' ' ' ILE . 8.1 pt -136.23 150.88 28.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.011 -175.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -113.53 124.46 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.16 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -74.8 116.64 15.74 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.4 mt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.579 -0.724 . . . . 0.0 111.579 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.863 0 N-CA-C 112.112 -0.395 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 53.8 m -137.58 93.54 2.81 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.057 0.456 . . . . 0.0 110.408 -178.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -81.48 82.9 7.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.021 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.58 -27.04 15.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.547 0.689 . . . . 0.0 109.535 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -126.9 103.06 7.29 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.122 -0.944 . . . . 0.0 109.931 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.69 0.76 31.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.677 -179.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 m -126.56 93.93 41.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.294 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.52 84.46 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.144 2.563 . . . . 0.0 112.103 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.493 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 64.7 t60 -84.9 135.3 40.08 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.717 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 5.9 Cg_endo -83.75 124.97 3.63 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.998 2.465 . . . . 0.0 111.924 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.02 -56.59 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.544 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.6 OUTLIER -73.96 110.83 8.57 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.268 0.556 . . . . 0.0 110.559 175.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 14.2 m-85 -118.84 165.28 14.23 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.4 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -129.73 114.52 16.08 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.996 176.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.405 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.5 t -80.47 135.12 36.07 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.772 -177.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.452 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.3 m-70 -75.81 -28.23 58.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.557 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.81 -45.53 18.59 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.245 0.545 . . . . 0.0 110.401 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.404 ' O ' HG13 ' A' ' 18' ' ' VAL . 81.3 m -86.87 -18.76 30.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.296 -177.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.8 p 51.61 39.68 25.51 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.044 0.938 . . . . 0.0 111.656 -175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 16' ' ' CYS . 28.2 m -133.88 164.57 34.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.054 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -83.15 128.15 34.23 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -131.2 167.63 25.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.509 0.671 . . . . 0.0 111.757 -173.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -115.28 108.96 46.99 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.142 167.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 37' ' ' ILE . 25.2 Cg_exo -62.71 149.41 91.3 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 122.992 2.461 . . . . 0.0 112.923 -171.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -71.23 99.43 1.9 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 170.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.22 -42.23 94.84 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -167.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -56.45 -21.65 38.56 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 121.985 1.79 . . . . 0.0 113.379 177.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HB2' HG12 ' A' ' 28' ' ' ILE . 17.6 m-20 -120.46 -18.95 7.72 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -177.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 61.13 36.09 18.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.603 -175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 ' HA ' ' HA2' ' A' ' 35' ' ' GLY . 22.6 pt -111.43 -172.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 121.479 0.657 . . . . 0.0 111.346 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.3 t -88.03 141.03 31.01 Favored Pre-proline 0 C--N 1.317 -0.848 0 CA-C-N 114.938 -1.028 . . . . 0.0 109.13 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.29 -9.37 12.66 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 121.978 1.785 . . . . 0.0 110.271 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -102.69 -42.09 6.01 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 114.859 -1.064 . . . . 0.0 111.701 -175.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.8 p -126.35 -6.88 6.43 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.763 -0.775 . . . . 0.0 112.62 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 59.02 37.42 24.44 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.146 0.498 . . . . 0.0 111.648 176.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 t -89.81 -57.43 2.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.775 -175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 28' ' ' ILE . . . 114.0 -24.64 11.55 Favored Glycine 0 N--CA 1.442 -0.925 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.521 -176.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.429 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 32.6 m-85 -67.83 82.1 0.2 Allowed 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.027 0.441 . . . . 0.0 111.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG21 HD11 ' A' ' 20' ' ' ILE . 6.4 pt -135.19 152.78 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.885 -177.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.452 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 40.3 mt-10 -114.3 127.96 56.12 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.654 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -78.97 108.3 12.35 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 90.3 mt . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.874 -170.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.042 0 N-CA-C 112.142 -0.383 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.7 t 64.11 -88.9 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.293 0.637 . . . . 0.0 111.743 175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp -84.16 -8.58 59.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.965 0.412 . . . . 0.0 110.435 -177.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.77 9.4 42.73 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.785 0.802 . . . . 0.0 108.929 176.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -116.95 29.5 7.88 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 114.614 -1.175 . . . . 0.0 109.939 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -103.81 17.32 24.35 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.693 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.461 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 33.4 t -62.18 -53.86 55.0 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 174.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 5' ' ' SER . 18.2 Cg_endo -60.12 133.53 50.56 Favored 'Trans proline' 0 C--N 1.359 1.086 0 C-N-CA 122.063 1.842 . . . . 0.0 111.579 174.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 43.9 p-80 -90.22 144.8 31.63 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.747 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -70.86 151.25 62.65 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.379 2.053 . . . . 0.0 111.64 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -159.11 -36.22 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.809 -178.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 3.8 ptp180 -80.36 109.87 15.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.537 0.684 . . . . 0.0 110.688 177.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.413 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 13.1 m-85 -121.0 163.86 17.62 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.196 177.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -128.38 109.3 11.31 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 176.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.475 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 19.4 t -74.26 127.75 33.77 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.757 -176.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 4.6 m170 -71.21 -28.08 63.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.523 177.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.564 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 61.4 m -79.4 -32.41 42.96 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.474 -176.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 70.9 m -104.41 -14.14 15.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.986 0.422 . . . . 0.0 111.602 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.7 p 52.01 42.73 30.56 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.097 0.959 . . . . 0.0 111.603 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.9 m -140.78 164.31 21.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.567 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 11' ' ' TYR . 4.3 tm-20 -88.18 130.42 35.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.73 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.495 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.56 167.21 24.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.459 0.647 . . . . 0.0 111.63 -171.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -116.56 105.2 50.54 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.735 169.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 25.7 Cg_exo -63.96 154.47 69.93 Favored 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 123.577 2.851 . . . . 0.0 114.042 -169.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -75.32 99.92 4.24 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 168.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.72 -48.48 97.19 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 -163.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.25 -25.08 45.0 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.197 1.931 . . . . 0.0 113.137 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -109.96 -17.02 13.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.902 0.382 . . . . 0.0 111.447 -178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 55.24 39.75 31.45 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.232 -0.895 . . . . 0.0 111.678 -176.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 24.4 pt -114.96 -177.05 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 CA-C-O 121.755 0.788 . . . . 0.0 112.012 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.7 t -88.71 143.57 32.03 Favored Pre-proline 0 C--N 1.315 -0.909 0 CA-C-N 114.227 -1.352 . . . . 0.0 109.415 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.44 -13.07 11.15 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 121.803 1.668 . . . . 0.0 110.946 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.418 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.6 mtp180 -95.65 -44.17 7.59 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.808 -178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.7 p -123.41 -10.18 7.98 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 119.898 -0.721 . . . . 0.0 112.71 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 56.05 37.33 28.73 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.083 0.468 . . . . 0.0 111.534 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.5 t -89.74 -56.62 3.17 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.385 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.2 -19.24 10.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.514 -0.85 . . . . 0.0 112.073 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 27.3 m-85 -73.95 85.19 1.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.849 0.356 . . . . 0.0 110.713 175.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -135.1 154.04 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.189 -177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 10.1 mm-40 -113.78 121.26 43.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.288 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -73.83 110.12 7.87 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.406 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 81.5 mt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.613 -0.708 . . . . 0.0 111.178 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.826 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 3' ' ' GLU . 45.0 m -114.48 145.39 41.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.756 0.312 . . . . 0.0 110.687 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.575 ' O ' ' HA ' ' A' ' 6' ' ' PRO . 4.7 mpp? -76.96 66.8 2.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.104 0.478 . . . . 0.0 110.338 179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -163.13 -38.88 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.783 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 0' ' ' SER . 14.6 pt-20 -71.0 -34.3 71.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.496 177.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.45 78.01 1.75 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.035 178.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.8 t 71.04 129.0 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.241 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.796 -178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 1' ' ' MET . 72.8 Cg_endo -77.78 34.71 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 122.826 2.351 . . . . 0.0 112.502 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.53 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 69.9 t60 68.57 125.83 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.211 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.526 -177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.53 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 14.2 Cg_exo -67.64 134.89 34.15 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 123.277 2.652 . . . . 0.0 111.87 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -155.07 -40.7 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.466 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.6 ptp180 -81.58 104.48 12.02 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.411 0.624 . . . . 0.0 110.315 175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 14.5 m-85 -121.9 166.57 14.21 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.462 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -128.23 109.17 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.68 175.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 20.1 t -75.15 130.97 40.11 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.524 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 4.6 m-70 -82.01 -16.09 51.44 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 76.7 m -84.65 -33.14 23.32 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.748 179.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.2 m -102.83 -15.0 16.36 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.179 0.514 . . . . 0.0 111.111 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 62.1 p 51.48 40.36 26.64 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.897 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -136.87 164.65 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.432 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -83.41 127.92 34.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.527 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.575 HD11 HG21 ' A' ' 37' ' ' ILE . 1.5 pt -132.9 168.06 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.369 0.604 . . . . 0.0 111.771 -171.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.27 105.76 48.18 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.803 169.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.8 Cg_exo -64.94 158.43 51.45 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 123.283 2.655 . . . . 0.0 113.697 -171.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -80.43 99.85 8.2 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 168.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.449 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.69 -44.84 99.86 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 113.972 1.101 . . . . 0.0 113.972 -166.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_exo -56.81 -24.04 53.71 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.975 1.783 . . . . 0.0 113.137 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.8 m-20 -111.67 -20.94 11.94 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.946 0.403 . . . . 0.0 111.613 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 59.77 36.41 22.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.396 -174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 27.7 pt -109.21 -175.85 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-O 121.702 0.763 . . . . 0.0 111.263 178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.3 t -88.37 141.08 30.4 Favored Pre-proline 0 C--N 1.313 -1.009 0 CA-C-N 114.673 -1.148 . . . . 0.0 109.766 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.04 -16.94 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.342 2.028 . . . . 0.0 110.698 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -91.74 -56.06 3.24 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.251 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 26.4 p -113.54 -9.32 13.28 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -170.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 59.51 31.7 21.18 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.894 0.378 . . . . 0.0 111.914 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 t -88.24 -56.89 3.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.839 -173.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.85 -23.0 7.52 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.102 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.565 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 47.8 m-85 -69.77 90.01 0.58 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.607 0.241 . . . . 0.0 111.047 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.575 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -141.37 154.81 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.929 0.395 . . . . 0.0 111.151 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.429 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.3 mt-10 -114.35 128.47 56.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.02 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -79.03 110.0 13.86 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.466 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.3 mt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 118.715 -0.659 . . . . 0.0 111.37 -174.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.829 0 N-CA-C 111.939 -0.464 . . . . 0.0 111.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 41.3 m 57.79 41.55 24.82 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 122.836 0.455 . . . . 0.0 111.734 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt 58.05 31.54 20.8 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.095 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.79 54.18 1.82 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.757 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 71.59 119.29 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.318 -177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.11 67.09 6.89 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.0 m -122.58 151.69 60.46 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.045 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.34 -61.46 0.59 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.049 2.499 . . . . 0.0 112.479 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 75.8 t60 70.43 133.17 0.04 OUTLIER Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 123.935 0.772 . . . . 0.0 111.929 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 49.4 Cg_endo -90.74 156.25 4.17 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 123.244 2.629 . . . . 0.0 112.36 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.01 -30.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.964 -179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -71.73 106.24 4.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.453 0.644 . . . . 0.0 111.094 176.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -120.01 167.61 12.0 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.194 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -132.59 113.45 13.06 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.836 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' HA ' HG22 ' A' ' 37' ' ' ILE . 17.7 t -78.64 131.12 36.56 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.518 -178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.434 ' HE2' ' CD ' ' A' ' 38' ' ' GLU . 3.9 m-70 -77.61 -26.66 50.8 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.809 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 63.5 m -77.38 -32.47 54.96 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.012 -178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.433 ' O ' HG13 ' A' ' 18' ' ' VAL . 73.4 m -102.98 -15.19 16.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.18 0.514 . . . . 0.0 111.177 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 48.78 45.63 21.93 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 114.787 -1.097 . . . . 0.0 111.481 -172.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -140.45 164.86 21.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.271 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -86.73 127.69 34.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.765 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.516 HD11 HG21 ' A' ' 37' ' ' ILE . 1.2 pt -133.65 168.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.323 0.582 . . . . 0.0 111.63 -172.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -118.53 111.39 38.04 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.451 168.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.86 152.16 80.97 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 C-N-CA 123.136 2.557 . . . . 0.0 113.871 -170.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -74.31 99.93 3.61 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 167.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -54.71 -47.6 97.65 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 114.006 1.114 . . . . 0.0 114.006 -164.425 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -55.84 -31.4 80.88 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.03 1.82 . . . . 0.0 112.971 177.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -97.91 -25.85 14.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.54 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 56.4 36.93 28.33 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.317 -173.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 30.3 pt -113.65 -174.59 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 CA-C-O 121.843 0.83 . . . . 0.0 111.689 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.455 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 42.0 t -88.48 142.14 30.99 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.19 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.46 -10.33 14.69 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.027 1.818 . . . . 0.0 110.731 178.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.455 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 10.6 mtp180 -101.41 -50.02 3.87 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.294 -177.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.6 p -118.17 -7.6 10.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 120.092 -0.643 . . . . 0.0 112.378 -173.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 58.1 34.8 24.57 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.171 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -88.86 -58.29 2.6 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.39 -19.11 10.84 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.011 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.405 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 25.1 m-85 -70.7 79.93 0.6 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.044 0.449 . . . . 0.0 110.886 175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.516 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -131.94 151.6 35.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.026 -178.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 34.1 mt-10 -115.22 124.03 50.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.112 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -72.29 116.78 13.13 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.521 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 86.8 mt . . . . . 0 C--O 1.245 0.865 0 CA-C-O 118.658 -0.687 . . . . 0.0 110.995 -174.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 31.8 p -81.42 -25.0 36.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.731 0.301 . . . . 0.0 111.198 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 mmt -83.73 52.13 2.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.346 0.593 . . . . 0.0 111.091 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.81 41.63 3.23 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.679 177.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 57.66 56.12 5.1 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.634 -174.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.34 -45.5 0.46 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.774 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.9 m -127.04 78.75 73.88 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.666 0.27 . . . . 0.0 111.376 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -88.73 29.57 0.44 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.886 2.391 . . . . 0.0 111.82 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -140.35 155.74 70.01 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.967 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.26 125.05 16.36 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.738 2.292 . . . . 0.0 112.319 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' VAL . . . -144.65 -47.79 0.04 OUTLIER Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.364 -177.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -81.91 106.63 13.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 121.528 0.68 . . . . 0.0 110.369 175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.407 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 12.3 m-85 -118.9 163.41 16.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.06 177.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -127.5 110.83 13.14 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.009 176.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' HA ' HG22 ' A' ' 37' ' ' ILE . 26.2 t -75.47 134.37 40.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.476 -177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -81.09 -25.4 37.05 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.236 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -76.87 -45.97 26.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.181 0.515 . . . . 0.0 110.257 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.408 ' O ' HG13 ' A' ' 18' ' ' VAL . 80.2 m -89.13 -16.64 30.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.092 -178.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.6 p 50.98 41.31 27.03 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 114.684 -1.144 . . . . 0.0 111.908 -175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.408 HG13 ' O ' ' A' ' 16' ' ' CYS . 30.3 m -136.78 164.06 31.48 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.274 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -82.62 131.27 35.21 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.484 HD11 HG21 ' A' ' 37' ' ' ILE . 1.6 pt -134.24 167.89 25.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.2 0.524 . . . . 0.0 111.058 -175.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 2.4 p -117.83 106.97 44.96 Favored Pre-proline 0 C--N 1.316 -0.857 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 23.7 Cg_exo -64.52 153.44 77.2 Favored 'Trans proline' 0 CA--C 1.515 -0.47 0 C-N-CA 123.21 2.607 . . . . 0.0 113.504 -170.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -69.97 99.48 1.43 Allowed 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 168.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -56.59 -40.65 86.48 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -168.426 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -54.78 -31.43 72.12 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.971 1.781 . . . . 0.0 113.007 175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -110.61 -18.94 13.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.992 0.425 . . . . 0.0 111.915 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 58.47 38.14 25.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.875 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 26.8 pt -115.33 -174.97 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-O 121.582 0.706 . . . . 0.0 111.731 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 48.9 t -87.66 138.6 31.52 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.152 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.73 -14.21 15.83 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.006 1.804 . . . . 0.0 110.593 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 mtp180 -94.71 -50.72 5.03 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.428 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 23.5 p -119.23 -6.92 10.35 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.889 -172.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 57.15 40.04 28.52 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.954 0.407 . . . . 0.0 111.375 176.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 13.0 t -89.87 -57.71 2.76 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.939 -0.573 . . . . 0.0 112.147 -172.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.78 -19.91 22.92 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.318 -175.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -73.36 77.61 1.37 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.931 0.396 . . . . 0.0 110.515 175.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 20' ' ' ILE . 9.1 pt -134.29 150.35 30.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -113.5 121.98 45.89 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.552 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -72.16 113.96 9.76 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 93.4 mt . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.786 -0.626 . . . . 0.0 111.33 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.908 -0.477 . . . . 0.0 111.908 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 77.5 p 50.04 78.58 0.1 Allowed 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.639 0.776 . . . . 0.0 111.894 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm -79.88 48.92 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.25 0.548 . . . . 0.0 110.748 178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.22 42.49 3.26 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.47 0.652 . . . . 0.0 109.762 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -94.45 13.71 23.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.096 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.18 -34.36 73.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.571 0.701 . . . . 0.0 109.32 174.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.4 m -107.41 106.72 59.11 Favored Pre-proline 0 N--CA 1.446 -0.66 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.907 169.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -47.7 -32.92 17.57 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.719 2.946 . . . . 0.0 113.622 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.4 p80 -145.56 137.2 12.93 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 110.327 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -59.06 158.65 24.65 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.794 2.329 . . . . 0.0 111.632 172.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.64 -51.75 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.467 -0.873 . . . . 0.0 112.164 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.9 OUTLIER -72.67 106.7 4.79 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.357 0.598 . . . . 0.0 111.131 178.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.84 166.15 14.82 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.561 176.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -129.92 111.07 12.2 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.528 175.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.2 t -74.73 129.81 38.37 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.42 -177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.4 m170 -80.3 -16.21 55.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.058 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.6 t -85.29 -41.54 15.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.267 0.556 . . . . 0.0 110.263 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.8 m -92.24 -16.12 26.58 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.239 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.7 p 50.64 42.06 26.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.635 -173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.1 m -137.68 163.63 30.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.192 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -86.08 125.67 33.62 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.669 -178.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -129.42 168.39 22.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.348 0.594 . . . . 0.0 111.765 -172.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.454 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -118.42 106.12 45.19 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.362 167.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.4 Cg_exo -66.35 160.15 46.76 Favored 'Trans proline' 0 CA--C 1.517 -0.374 0 C-N-CA 123.316 2.677 . . . . 0.0 114.241 -169.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -77.18 100.37 5.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 167.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.65 -42.95 98.9 Favored Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 -167.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -54.83 -36.02 90.09 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.313 2.009 . . . . 0.0 113.46 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -102.01 -19.22 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.998 0.428 . . . . 0.0 111.652 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 58.74 41.04 22.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.477 -175.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.0 pt -115.79 -174.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 121.618 0.723 . . . . 0.0 111.705 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.4 t -87.56 141.49 32.22 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.96 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -79.89 -9.67 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.765 1.643 . . . . 0.0 110.001 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -98.47 -60.7 1.49 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.999 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.9 p -107.74 -8.04 16.19 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 120.245 -0.582 . . . . 0.0 112.153 -172.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 57.09 35.9 26.93 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.971 174.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 12.0 t -90.4 -58.28 2.55 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.006 -174.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 122.71 -24.55 6.75 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.432 -0.89 . . . . 0.0 111.845 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -68.55 85.41 0.29 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 0.0 110.917 175.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -138.37 152.17 25.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.646 -178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -113.92 121.71 44.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.287 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -74.01 103.13 4.38 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.575 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 93.1 mt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.855 -0.593 . . . . 0.0 112.382 -170.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 111.964 -0.455 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 36.8 t -144.51 135.33 24.92 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt 54.38 43.26 30.7 Favored 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.594 0.559 . . . . 0.0 110.836 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.11 -20.6 13.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.702 -174.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -150.19 -65.97 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.47 178.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.49 -86.01 0.02 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.837 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.493 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 23.1 t 53.56 59.77 12.4 Favored Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.22 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HD3' ' N ' ' A' ' 5' ' ' SER . 86.8 Cg_endo -102.57 15.55 0.29 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.312 2.675 . . . . 0.0 113.485 -177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.7 p80 -120.4 149.17 49.24 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.983 -175.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -73.55 163.79 36.6 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.417 2.078 . . . . 0.0 111.458 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.74 -50.44 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.535 -0.84 . . . . 0.0 112.233 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.66 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -70.39 107.59 3.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.233 0.54 . . . . 0.0 110.832 178.048 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -121.09 165.87 14.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.647 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -131.47 111.77 12.08 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.92 176.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 18.5 t -75.35 133.25 41.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.597 -177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.0 m170 -80.29 -19.14 47.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.634 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.5 t -86.49 -43.0 13.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.178 0.513 . . . . 0.0 110.504 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' O ' HG13 ' A' ' 18' ' ' VAL . 71.5 m -86.93 -17.52 32.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.992 -179.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.5 p 50.49 43.28 27.2 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.457 -173.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 16' ' ' CYS . 32.9 m -138.34 164.73 26.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.35 179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -84.69 129.77 34.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.2 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.23 168.08 24.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.597 0.713 . . . . 0.0 111.862 -173.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 p -117.77 106.7 45.55 Favored Pre-proline 0 C--N 1.319 -0.751 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.398 168.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.8 Cg_exo -63.87 152.78 79.21 Favored 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.171 2.581 . . . . 0.0 113.761 -170.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -75.68 100.28 4.61 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 170.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -47.99 93.54 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -163.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.54 -29.03 58.09 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.092 1.861 . . . . 0.0 113.008 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HB2' HG12 ' A' ' 28' ' ' ILE . 21.0 m-20 -110.14 -16.62 13.74 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.153 0.502 . . . . 0.0 111.253 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 53.75 38.36 28.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.008 -0.997 . . . . 0.0 111.61 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 26' ' ' ASP . 23.2 pt -107.34 -175.03 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.597 0.713 . . . . 0.0 111.444 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.8 t -87.7 140.24 31.47 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.247 -178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -81.18 -7.66 13.0 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.994 1.796 . . . . 0.0 110.346 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -104.0 -41.78 5.75 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.722 -175.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 24.7 p -127.01 -8.32 5.99 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 119.612 -0.835 . . . . 0.0 112.849 -177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 56.51 42.15 27.73 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.031 0.443 . . . . 0.0 111.565 176.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 t -94.54 -57.1 2.58 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.219 -174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.9 -26.02 7.32 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.645 -178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.2 m-85 -68.01 85.33 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.865 0.364 . . . . 0.0 111.204 176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 HD11 ' A' ' 20' ' ' ILE . 7.4 pt -136.71 153.11 29.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.698 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' CD ' ' HE2' ' A' ' 14' ' ' HIS . 27.2 mt-10 -113.53 127.68 56.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.157 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -78.4 112.77 15.77 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.66 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 88.6 mt . . . . . 0 C--O 1.247 0.927 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.573 -171.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 9.8 p -97.28 -22.51 16.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.658 0.229 . . . . 0.0 110.818 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt 70.39 -66.98 0.26 Allowed 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.878 0.737 . . . . 0.0 111.218 178.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.41 45.62 0.99 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.561 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -46.47 -55.2 7.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.755 -1.112 . . . . 0.0 111.838 -179.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.49 32.95 1.3 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.943 -175.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -152.3 124.65 3.94 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.752 -0.204 . . . . 0.0 110.713 178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.33 124.22 14.49 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.566 2.177 . . . . 0.0 111.244 175.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 27.0 p-80 -144.32 143.18 21.18 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.267 -172.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -74.42 132.04 15.76 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.718 2.279 . . . . 0.0 111.367 175.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.77 -49.51 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.504 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.637 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.09 106.58 10.06 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.33 0.586 . . . . 0.0 110.459 176.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -121.43 165.88 14.93 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -129.43 112.6 13.97 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.779 176.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.465 ' HA ' HG22 ' A' ' 37' ' ' ILE . 34.5 t -76.94 135.53 38.76 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 -177.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 3.5 m-70 -83.1 -25.49 31.94 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.122 0.487 . . . . 0.0 110.653 177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 28.1 m -74.86 -39.91 61.28 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 77.6 m -97.46 -17.63 19.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.006 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 13' ' ' CYS . 38.4 p 50.18 45.96 25.24 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.544 -172.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 33.9 m -140.13 165.26 21.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.202 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -83.66 127.76 34.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.611 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.557 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -133.79 167.98 25.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.422 0.629 . . . . 0.0 111.554 -174.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -117.44 110.9 40.34 Favored Pre-proline 0 C--N 1.318 -0.772 0 CA-C-N 114.521 -1.218 . . . . 0.0 108.073 167.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 24.6 Cg_exo -63.96 150.56 88.12 Favored 'Trans proline' 0 CA--C 1.516 -0.417 0 C-N-CA 122.95 2.433 . . . . 0.0 113.17 -171.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -72.7 99.18 2.53 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 170.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.413 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.4 OUTLIER -53.31 -42.93 93.9 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 114.738 1.385 . . . . 0.0 114.738 -165.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.0 -27.74 37.16 Favored 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 122.196 1.931 . . . . 0.0 113.336 177.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -119.48 -14.22 9.16 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 58.21 35.67 25.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.746 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 15.6 pt -107.23 -173.73 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 111.048 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 46.3 t -87.38 142.92 33.59 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.182 -178.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -84.43 -6.21 10.03 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 121.876 1.717 . . . . 0.0 110.31 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.456 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 28.1 mtt180 -104.93 -36.16 7.44 Favored 'General case' 0 N--CA 1.442 -0.832 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.758 -177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -132.04 -6.73 3.48 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 56.14 35.8 26.3 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.974 0.416 . . . . 0.0 111.912 175.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.6 t -93.98 -57.07 2.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.364 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.91 -18.06 10.64 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.325 -0.94 . . . . 0.0 112.181 178.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 37.2 m-85 -69.0 82.8 0.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.038 0.447 . . . . 0.0 110.651 174.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.557 HG21 HD11 ' A' ' 20' ' ' ILE . 8.3 pt -137.0 150.67 26.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.576 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -113.98 128.67 56.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.89 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -77.99 111.17 13.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.637 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 95.8 mt . . . . . 0 C--O 1.251 1.147 0 CA-C-O 118.775 -0.631 . . . . 0.0 111.786 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 111.875 -0.49 . . . . 0.0 111.875 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 7.3 t 58.14 29.23 17.59 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 121.412 0.625 . . . . 0.0 110.684 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.6 ttm -92.98 -60.35 1.83 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.73 -24.54 22.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.898 174.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 60.79 44.18 11.3 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 114.616 -1.174 . . . . 0.0 110.73 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 62.03 -178.44 0.13 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.221 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -154.77 91.33 2.99 Favored Pre-proline 0 C--N 1.32 -0.674 0 CA-C-O 121.109 0.48 . . . . 0.0 110.468 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -74.81 -13.51 21.85 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.669 2.246 . . . . 0.0 110.617 173.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.1 p80 -170.8 126.76 0.67 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 114.893 -1.048 . . . . 0.0 109.494 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 36.6 Cg_endo -88.14 -63.75 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.797 2.332 . . . . 0.0 111.751 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.52 -40.48 0.54 Allowed Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 175.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.618 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 2.3 ptp180 -73.24 116.1 13.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.698 -0.751 . . . . 0.0 111.475 177.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.0 m-85 -130.27 165.07 23.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.032 171.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -130.62 112.54 13.23 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.83 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.0 t -77.8 135.76 38.01 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.649 -177.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -86.9 -14.08 42.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.564 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -85.97 -37.7 18.73 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.363 0.602 . . . . 0.0 110.007 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.415 ' CB ' HG22 ' A' ' 18' ' ' VAL . 77.7 m -96.78 -17.65 20.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.361 -179.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.7 p 50.55 43.12 27.45 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.264 1.025 . . . . 0.0 111.541 -173.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 16' ' ' CYS . 34.0 m -137.95 163.83 29.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.355 179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -84.85 126.34 33.38 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.762 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.535 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.26 168.54 23.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.371 0.605 . . . . 0.0 111.464 -172.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -118.01 111.23 39.07 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 114.802 -1.09 . . . . 0.0 108.445 167.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' HG3' HD12 ' A' ' 37' ' ' ILE . 27.7 Cg_exo -62.43 145.65 95.66 Favored 'Trans proline' 0 CA--C 1.516 -0.421 0 C-N-CA 122.876 2.384 . . . . 0.0 113.366 -171.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -68.77 100.33 1.15 Allowed 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 169.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.11 -46.58 99.65 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 -163.827 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -55.32 -26.33 51.97 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.211 1.941 . . . . 0.0 113.231 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -114.5 -14.72 12.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.897 0.38 . . . . 0.0 111.977 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 56.5 38.45 29.66 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.976 -177.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 18.7 pt -114.13 -170.7 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.403 0.621 . . . . 0.0 111.447 -178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.7 t -88.32 140.74 30.41 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.473 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.71 -12.55 14.98 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.203 1.935 . . . . 0.0 110.597 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -97.9 -49.18 4.89 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 115.029 -0.987 . . . . 0.0 111.549 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.0 p -121.3 -6.27 9.36 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 119.983 -0.687 . . . . 0.0 112.772 -172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 55.99 38.86 30.42 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.847 0.356 . . . . 0.0 111.75 178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.0 t -88.23 -57.96 2.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.668 -174.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.02 -24.8 11.35 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.502 -0.856 . . . . 0.0 111.591 -177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -68.92 82.95 0.31 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.945 0.403 . . . . 0.0 110.699 175.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.535 HG21 HD11 ' A' ' 20' ' ' ILE . 8.7 pt -135.89 151.61 29.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.674 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 30.3 mt-10 -112.85 127.93 56.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.953 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -79.91 107.25 12.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 176.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.618 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 98.9 mt . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.253 -0.879 . . . . 0.0 112.603 -167.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 28.9 p -77.61 127.72 32.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.686 0.279 . . . . 0.0 111.221 -177.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt 59.08 74.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.144 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.96 20.62 18.5 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.088 176.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 58.51 39.64 24.72 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.143 -179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.06 -8.85 58.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.516 178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 18.6 m -101.69 -50.13 0.17 Allowed Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.831 176.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.493 ' HD3' ' HB2' ' A' ' 5' ' ' SER . 6.7 Cg_exo -73.4 85.68 1.24 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.36 2.04 . . . . 0.0 112.461 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -175.18 157.81 2.07 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 108.552 -0.906 . . . . 0.0 108.552 177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.5 119.36 6.45 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 121.895 1.73 . . . . 0.0 111.174 173.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.07 -40.66 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.81 -0.709 . . . . 0.0 111.591 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -90.98 104.56 17.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.397 0.618 . . . . 0.0 110.508 174.691 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.417 ' CD1' ' HG2' ' A' ' 22' ' ' PRO . 13.7 m-85 -115.14 168.14 10.21 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.463 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -130.62 113.92 14.8 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.895 176.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.501 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.3 t -78.85 132.17 36.73 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.801 -177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -76.5 -22.55 54.32 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.511 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.3 t -84.31 -45.58 12.67 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.05 0.452 . . . . 0.0 110.385 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.4 m -85.67 -18.68 32.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.005 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 71.1 p 50.72 46.23 26.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.365 -174.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.435 HG21 HH11 ' A' ' 31' ' ' ARG . 35.2 m -140.25 164.77 22.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.232 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -85.58 126.42 33.87 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.375 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.533 HD11 HG21 ' A' ' 37' ' ' ILE . 1.4 pt -131.59 167.02 27.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.562 0.696 . . . . 0.0 111.943 -173.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.51 105.18 48.67 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 114.609 -1.178 . . . . 0.0 108.42 169.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 21.6 Cg_exo -65.66 156.49 63.6 Favored 'Trans proline' 0 CA--C 1.516 -0.41 0 C-N-CA 123.345 2.697 . . . . 0.0 114.142 -169.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -76.14 100.3 4.95 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 168.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.65 -46.46 98.27 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 -165.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -53.84 -34.71 76.7 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.116 1.877 . . . . 0.0 113.576 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -108.55 -11.38 15.13 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 54.26 41.32 32.05 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.781 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 13.6 pt -110.71 -174.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.586 0.708 . . . . 0.0 111.876 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -88.18 140.65 30.64 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 114.875 -1.057 . . . . 0.0 109.375 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -80.9 -10.66 12.73 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 121.902 1.735 . . . . 0.0 110.26 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.435 HH11 HG21 ' A' ' 18' ' ' VAL . 9.7 mtp180 -97.54 -48.27 5.33 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.838 -1.074 . . . . 0.0 111.636 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.4 p -124.21 -4.66 7.89 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -174.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 55.6 41.48 30.56 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.152 0.501 . . . . 0.0 111.386 177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.0 t -88.3 -57.26 2.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.13 -173.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.01 -23.98 17.65 Favored Glycine 0 N--CA 1.442 -0.956 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.319 -175.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -72.39 80.1 1.03 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.791 0.329 . . . . 0.0 110.569 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.533 HG21 HD11 ' A' ' 20' ' ' ILE . 8.4 pt -134.65 153.49 35.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.743 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -113.42 126.55 55.47 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.218 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.52 101.95 5.86 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.411 179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 80.9 mt . . . . . 0 C--O 1.244 0.804 0 CA-C-O 118.457 -0.782 . . . . 0.0 111.212 -173.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.783 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 14.8 m -65.84 -49.61 67.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.0 0.428 . . . . 0.0 111.14 -178.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -111.81 83.5 1.8 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.913 0.387 . . . . 0.0 110.588 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 3' ' ' GLU . . . -158.7 59.51 0.43 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.782 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 2' ' ' ALA . 43.4 tt0 73.23 -63.28 0.44 Allowed 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.718 0.636 . . . . 0.0 110.797 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.6 -175.12 5.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.135 177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.3 m 64.14 93.52 0.06 OUTLIER Pre-proline 0 C--N 1.33 -0.243 0 O-C-N 123.761 0.663 . . . . 0.0 110.728 -178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.03 -164.33 0.21 Allowed 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.623 2.215 . . . . 0.0 112.55 -178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 36.4 p-80 -55.61 129.15 70.04 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.061 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 20.0 Cg_exo -66.39 139.34 53.95 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.58 2.187 . . . . 0.0 111.487 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -147.85 -50.97 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.968 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.636 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 1.4 ptp180 -75.11 107.1 6.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.401 0.619 . . . . 0.0 110.979 177.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -121.57 168.04 12.19 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.138 175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -131.42 111.1 11.52 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.029 176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 23.0 t -76.64 136.93 39.18 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.49 -178.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 36' ' ' PHE . 2.5 m-70 -83.76 -26.81 29.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.149 178.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 23.8 t -76.15 -37.5 57.88 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.206 0.527 . . . . 0.0 110.272 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.434 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 81.6 m -96.2 -16.91 21.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.955 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.8 p 51.5 40.45 26.89 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.929 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.62 165.28 27.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.491 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -82.76 132.16 35.18 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.911 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.546 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -138.24 167.91 20.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.405 0.621 . . . . 0.0 111.8 -172.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -117.23 107.62 45.12 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.504 168.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 22.9 Cg_exo -65.44 148.03 87.57 Favored 'Trans proline' 0 CA--C 1.516 -0.378 0 C-N-CA 123.157 2.571 . . . . 0.0 113.816 -170.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -76.47 100.41 5.23 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -56.32 -43.26 99.21 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -164.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.27 -34.01 68.01 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.055 1.836 . . . . 0.0 112.914 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -106.06 -15.26 14.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.466 0.65 . . . . 0.0 110.846 178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 57.08 40.05 28.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.226 -177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.1 pt -115.41 -169.07 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.577 0.704 . . . . 0.0 111.932 -176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.2 t -87.79 142.59 32.6 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.509 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.65 -7.17 12.58 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.121 1.881 . . . . 0.0 110.604 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.434 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 3.0 mtp180 -102.72 -49.27 3.86 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.388 -177.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.4 p -120.98 -8.33 9.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 120.005 -0.678 . . . . 0.0 112.546 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 57.04 37.49 28.73 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.884 0.373 . . . . 0.0 111.811 178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.1 t -86.86 -57.22 3.06 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.161 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.43 -22.23 13.73 Favored Glycine 0 N--CA 1.443 -0.866 0 C-N-CA 120.658 -0.782 . . . . 0.0 111.407 -175.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HB3' ' HB2' ' A' ' 14' ' ' HIS . 41.4 m-85 -70.69 82.37 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.74 0.305 . . . . 0.0 110.981 175.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 HD11 ' A' ' 20' ' ' ILE . 6.8 pt -136.48 152.2 29.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.902 0.382 . . . . 0.0 110.942 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -114.54 128.44 56.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.933 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -79.06 115.41 18.71 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.636 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 92.5 mt . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.462 -174.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 N-CA-C 111.92 -0.472 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 60.1 m -119.25 90.02 3.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.02 0.438 . . . . 0.0 110.911 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -120.87 126.9 51.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.943 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.85 33.23 1.78 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.133 0.492 . . . . 0.0 110.965 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -98.22 -83.83 0.4 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.177 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -159.16 -51.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.798 177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.2 t -170.73 74.9 0.57 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.551 177.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.54 136.13 69.21 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.737 2.291 . . . . 0.0 112.083 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 12.5 p80 -132.88 126.21 19.64 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.772 -178.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 7' ' ' HIS . 13.8 Cg_exo -68.94 135.53 32.69 Favored 'Trans proline' 0 N--CA 1.464 -0.256 0 C-N-CA 122.833 2.355 . . . . 0.0 111.843 178.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -140.7 -42.77 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.379 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.606 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -78.72 112.6 16.01 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.436 0.636 . . . . 0.0 110.644 177.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 12.9 m-85 -123.83 166.6 15.34 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.212 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -129.85 110.52 11.78 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 120.959 0.409 . . . . 0.0 109.936 175.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 15' ' ' CYS . 28.5 t -75.19 132.94 41.48 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.822 -176.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.2 m170 -81.9 -17.85 45.76 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.665 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.545 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 68.8 m -85.81 -31.52 22.26 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.876 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 31' ' ' ARG . 71.6 m -104.82 -16.83 14.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.263 179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.8 p 52.44 40.56 29.78 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.619 -173.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.0 m -135.52 163.99 33.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.399 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.39 126.84 33.6 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.206 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.536 HD11 HG21 ' A' ' 37' ' ' ILE . 1.7 pt -133.44 167.8 25.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 121.339 0.59 . . . . 0.0 112.088 -171.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.2 p -117.79 107.23 44.65 Favored Pre-proline 0 C--N 1.319 -0.742 0 CA-C-N 114.63 -1.168 . . . . 0.0 108.502 168.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 28.0 Cg_exo -62.72 151.74 82.14 Favored 'Trans proline' 0 CA--C 1.519 -0.247 0 C-N-CA 123.391 2.727 . . . . 0.0 113.746 -171.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -75.13 100.71 4.34 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 171.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -44.83 99.93 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -164.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -54.62 -23.95 34.72 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.299 1.999 . . . . 0.0 113.482 177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HB2' HG12 ' A' ' 28' ' ' ILE . 12.0 m-20 -115.48 -16.11 11.41 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.828 0.346 . . . . 0.0 111.858 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 56.63 37.52 28.88 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.301 -173.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 26' ' ' ASP . 22.5 pt -110.52 -175.45 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 121.616 0.722 . . . . 0.0 111.652 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -88.17 140.38 30.63 Favored Pre-proline 0 C--N 1.313 -0.993 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.667 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.27 -14.51 16.46 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.056 1.837 . . . . 0.0 110.919 178.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.448 ' HB2' ' SG ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -96.52 -44.67 7.07 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.745 -178.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.5 p -123.25 -8.81 8.14 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 119.812 -0.755 . . . . 0.0 112.961 -174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 59.15 31.93 21.67 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.968 0.414 . . . . 0.0 111.618 175.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.8 t -89.97 -57.08 2.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.676 -173.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.66 -21.89 8.37 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.38 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.545 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 9.0 m-85 -71.44 87.86 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.824 0.345 . . . . 0.0 110.666 176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.536 HG21 HD11 ' A' ' 20' ' ' ILE . 6.2 pt -137.66 155.86 31.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.1 mt-10 -114.33 123.5 49.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.061 178.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -73.4 112.6 9.63 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.606 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 96.9 mt . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.497 -0.763 . . . . 0.0 111.876 -172.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.804 0 N-CA-C 112.093 -0.403 . . . . 0.0 112.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 22.9 t -127.86 100.53 5.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.895 0.378 . . . . 0.0 110.127 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -88.93 4.87 46.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.814 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.82 -62.12 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.604 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -170.52 -100.04 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.146 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' HB2' HH12 ' A' ' 10' ' ' ARG . . . 47.52 62.23 2.54 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 32.8 t -172.59 -59.0 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 111.636 0.235 . . . . 0.0 111.636 176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -61.68 -35.75 78.58 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 121.985 1.79 . . . . 0.0 113.052 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -172.27 151.62 2.58 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.409 -177.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -79.44 135.66 11.98 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.402 2.068 . . . . 0.0 110.97 172.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.4 -33.77 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.969 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.547 ' HD2' ' O ' ' A' ' 40' ' ' LEU . 0.8 OUTLIER -85.3 112.91 21.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.304 0.573 . . . . 0.0 110.119 175.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -123.46 167.12 14.28 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.71 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -130.34 112.07 12.95 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.697 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HA ' HG22 ' A' ' 37' ' ' ILE . 19.7 t -78.6 132.92 37.3 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.477 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -79.9 -27.93 39.91 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.798 178.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.445 ' HB2' ' SG ' ' A' ' 13' ' ' CYS . 73.5 m -73.76 -32.87 64.03 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -103.18 -16.66 15.65 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.22 0.533 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.8 p 50.12 43.99 25.93 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.745 -172.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.1 m -139.94 162.93 25.04 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.398 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -82.15 127.75 33.46 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.228 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.531 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -132.59 167.31 26.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.506 0.669 . . . . 0.0 111.872 -172.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.439 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.3 p -115.38 107.76 48.73 Favored Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.451 168.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 36.5 Cg_exo -61.64 146.55 96.73 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 C-N-CA 123.068 2.512 . . . . 0.0 113.024 -172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 100.0 mtt180 -74.14 99.9 3.5 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 171.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.424 HD22 ' HA ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -55.31 -41.19 89.47 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -168.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -47.37 -28.87 8.95 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.479 2.119 . . . . 0.0 113.94 175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.405 ' HB2' HG12 ' A' ' 28' ' ' ILE . 10.8 m-20 -126.26 -5.38 6.64 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER 52.58 39.57 28.36 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.683 -175.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.405 HG12 ' HB2' ' A' ' 26' ' ' ASP . 12.9 pt -112.66 -169.44 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.357 0.599 . . . . 0.0 111.454 -178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.499 ' SG ' ' HG3' ' A' ' 31' ' ' ARG . 46.5 t -87.4 141.97 32.86 Favored Pre-proline 0 C--N 1.315 -0.93 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.327 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.412 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 72.3 Cg_endo -78.89 -9.47 15.6 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.846 1.698 . . . . 0.0 110.549 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.499 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 5.8 mtp-105 -101.04 -58.54 1.87 Allowed 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.122 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.9 p -111.2 -5.91 14.65 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.436 -0.505 . . . . 0.0 112.14 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 55.43 35.83 25.85 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.198 176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -89.83 -57.74 2.76 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.947 -174.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.73 -15.94 19.09 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.118 -178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -70.3 77.68 0.54 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.926 0.393 . . . . 0.0 110.447 175.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 HD11 ' A' ' 20' ' ' ILE . 8.0 pt -132.21 153.57 38.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.207 -175.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -113.82 125.56 54.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -77.28 107.76 9.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 176.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' O ' ' HD2' ' A' ' 10' ' ' ARG . 91.3 mt . . . . . 0 C--O 1.251 1.165 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.113 -170.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.826 -0.509 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.3 p -121.83 -5.15 9.12 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.812 0.339 . . . . 0.0 111.121 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -139.44 167.4 22.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.754 -177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.89 25.11 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.933 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -106.9 162.33 13.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.627 -175.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 65.66 -81.52 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.323 0 O-C-N 123.964 0.79 . . . . 0.0 111.639 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.684 ' H ' ' HD2' ' A' ' 6' ' ' PRO . 15.2 m -133.9 -58.0 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.563 -176.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.684 ' HD2' ' H ' ' A' ' 5' ' ' SER . 9.3 Cg_endo -52.52 132.57 45.81 Favored 'Trans proline' 0 C--N 1.36 1.18 0 C-N-CA 122.35 2.034 . . . . 0.0 112.269 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -148.64 132.99 8.81 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.985 -179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -81.99 160.89 18.36 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.681 2.254 . . . . 0.0 111.879 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -146.22 -43.14 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.98 -176.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.659 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.9 ptp180 -75.15 106.14 6.51 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.491 0.662 . . . . 0.0 110.398 176.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 13.1 m-85 -119.67 162.76 18.47 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.331 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -128.11 110.67 12.69 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.967 177.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HA ' HG22 ' A' ' 37' ' ' ILE . 32.7 t -76.16 132.79 40.2 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.819 -176.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -81.18 -22.51 38.86 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.735 177.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.555 ' SG ' ' HB2' ' A' ' 36' ' ' PHE . 78.4 m -80.49 -29.34 37.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.083 -179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 75.8 m -107.84 -16.49 14.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.308 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.1 p 51.51 43.47 29.63 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.207 1.003 . . . . 0.0 111.754 -173.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.8 m -139.97 164.17 23.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.222 178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -84.45 131.12 34.7 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.849 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.576 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -136.6 167.31 24.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.417 0.627 . . . . 0.0 111.869 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.1 p -114.99 108.94 47.62 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.343 167.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 21' ' ' VAL . 18.0 Cg_exo -66.98 153.78 76.8 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.905 2.404 . . . . 0.0 113.717 -171.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -79.39 99.63 7.26 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 170.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.68 -41.77 91.53 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 -167.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_exo -44.44 -50.11 8.36 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.444 2.096 . . . . 0.0 113.312 176.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -100.4 -13.65 18.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.208 0.528 . . . . 0.0 111.117 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 59.68 37.56 22.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.721 -176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 16.7 pt -106.96 -174.84 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.634 0.73 . . . . 0.0 111.75 -176.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.0 t -87.56 142.84 33.22 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.532 -1.213 . . . . 0.0 109.042 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -80.8 -7.42 13.41 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 121.874 1.716 . . . . 0.0 110.601 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -101.71 -57.19 2.12 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.937 -177.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 29.3 p -110.61 -9.1 14.55 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.712 -173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 57.76 35.14 25.24 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.681 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.5 t -92.87 -57.98 2.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.053 -0.521 . . . . 0.0 112.005 -174.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.34 -19.55 9.22 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.129 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 41.4 m-85 -68.47 86.37 0.3 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.695 0.283 . . . . 0.0 110.825 174.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.576 HG21 HD11 ' A' ' 20' ' ' ILE . 5.8 pt -139.38 151.26 22.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.879 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -113.71 129.0 56.64 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.6 115.78 17.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 177.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.659 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 87.6 mt . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.829 -172.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 42.4 m -66.89 139.15 57.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.679 0.276 . . . . 0.0 110.852 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 67.36 8.85 6.56 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.36 -178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.54 -17.93 7.38 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.947 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.57 68.91 9.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.244 0.545 . . . . 0.0 110.811 -176.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.65 18.71 10.36 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.376 0.607 . . . . 0.0 109.882 175.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -131.26 96.29 22.26 Favored Pre-proline 0 N--CA 1.445 -0.704 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.497 -177.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -67.29 -29.02 39.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.288 1.992 . . . . 0.0 109.732 170.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -124.42 132.85 24.35 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 114.235 -1.348 . . . . 0.0 108.2 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -75.37 -71.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.27 1.98 . . . . 0.0 112.75 -174.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 143.08 -32.72 1.88 Allowed Glycine 0 CA--C 1.506 -0.52 0 C-N-CA 120.686 -0.768 . . . . 0.0 111.269 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.683 ' HD2' ' OXT' ' A' ' 40' ' ' LEU . 1.2 ptp180 -68.68 106.26 2.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.444 0.64 . . . . 0.0 110.763 176.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 38' ' ' GLU . 11.3 m-85 -124.31 164.79 18.87 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.376 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -129.36 111.15 12.53 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.881 177.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HA ' HG22 ' A' ' 37' ' ' ILE . 13.1 t -76.71 130.97 38.48 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.718 -177.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -71.29 -29.86 65.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.127 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 13' ' ' CYS . 29.6 t -75.19 -50.73 15.31 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.286 0.565 . . . . 0.0 110.982 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.402 ' O ' HG13 ' A' ' 18' ' ' VAL . 74.8 m -83.3 -18.74 37.98 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.267 -175.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 84.1 p 51.9 40.43 27.99 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.181 0.992 . . . . 0.0 111.34 -174.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 16' ' ' CYS . 27.2 m -136.25 164.97 30.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.168 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.32 129.36 34.88 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.28 179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.537 HD11 HG21 ' A' ' 37' ' ' ILE . 1.3 pt -134.17 167.36 26.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.234 0.54 . . . . 0.0 111.318 -173.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 2.4 p -116.37 109.57 44.0 Favored Pre-proline 0 C--N 1.317 -0.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 108.577 168.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG3' HD12 ' A' ' 37' ' ' ILE . 36.7 Cg_exo -62.6 149.47 90.99 Favored 'Trans proline' 0 C--O 1.236 0.381 0 C-N-CA 123.224 2.616 . . . . 0.0 113.654 -171.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -74.17 100.73 3.74 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.02 -43.76 99.23 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -166.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.71 -28.0 45.05 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.117 1.878 . . . . 0.0 113.491 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -118.55 -12.8 9.74 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 57.27 39.58 28.48 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.628 -176.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 14.4 pt -110.72 -173.37 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.433 0.635 . . . . 0.0 111.698 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 45.9 t -87.73 140.25 31.41 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.294 -178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.26 -17.35 16.94 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 121.832 1.688 . . . . 0.0 110.617 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -92.07 -59.76 2.02 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.116 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.42 -6.6 14.91 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.532 -170.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 56.37 40.67 29.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.932 177.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.2 t -88.65 -58.19 2.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.264 -0.425 . . . . 0.0 112.072 -174.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.26 -25.9 9.54 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.6 -176.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -71.71 84.49 0.89 Allowed 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.147 0.498 . . . . 0.0 110.827 176.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.537 HG21 HD11 ' A' ' 20' ' ' ILE . 6.5 pt -135.57 152.47 31.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.7 -177.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 66.6 mm-40 -114.06 128.09 56.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -82.7 113.46 20.39 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.683 ' OXT' ' HD2' ' A' ' 10' ' ' ARG . 88.1 mt . . . . . 0 C--O 1.249 1.027 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.622 -171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_